「the solutioninthe」の検索結果
141件：56～60件目を表示
-
, Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for NAVIS” in Japan. MIEr for NAVIS can sharpen imag...
https://www.senju.co.jp/sites/default/files/content_news/2024-04/ENG_20240423.pdf -
ルミガン点眼液0.03％
oodward, D.F. et al.：J. Ophthalmol., 2010, 926192, 2010. ４）Woodward, D.F. et al.：J. Pharmacol. Exp. Ther., 305, 772, 2003. ５）Kothari, M.T. et al.：Indian J. Ophthalmol., 54, 47, 2006. ６）Kroll, D.M. et ...
https://www.senju.co.jp/sites/default/files/2020-09/RM_IF.pdf -
. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for BeelineMED” in Japan. MIEr for BeelineMED is cap...
https://www.senju.co.jp/sites/default/files/content_news/2025-02/ENG_20250220.pdf -
研究開発の取り組み | 千寿製薬株式会社
earch and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, plea...
http://www.senju.co.jp/english/rd/ -
ers: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this &qu...
https://www.senju.co.jp/sites/default/files/content_news/2024-08/ENG_20240903_0.pdf